Paid Clinical Trials in Silver Spring, MD
As of June 2026, 70 paid clinical trials are recruiting in Silver Spring, Maryland. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Silver Spring offers studies at sites including Holy Cross Hospital for conditions such as Breast Cancer, Endometrial Cancer, Carcinoma, Non-Small-Cell Lung, Asthma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Silver Spring
Trials by drug in Silver Spring
Filter results
69 clinical trials
↓ Download CSVA Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Creating a Flexible Curriculum Tool for Pediatric Palliative Care Rotating Learners
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Long-Term Stability of the Glide Control Strategy
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
TANDem-2: Closing the Gap to Interventions for TAND
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
The Effects of Propranolol and Hydrocortisone on Military-Relevant Performance Outcomes
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
Long-term Safety and Tolerability of BHV-7000
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Boosting Resources for Tracheostomy Care at Home
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Comparing Use of Incentive Spirometry With and Without Reminder
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
About research studies in Silver Spring
Silver Spring has approximately 70 recruiting research studies across a wide range of therapeutic areas. Maryland hosts Johns Hopkins Medicine and the NIH Clinical Center in Bethesda, giving participants access to some of the most advanced early-phase research in the country.
Top Research Study Locations in Silver Spring
Researchers run research studies in Silver Spring, MD at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Holy Cross Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Carcinoma, Ovarian Epithelial, Elevated CA15-3 or CEA or CA27-29 | 13 |
| Maryland Oncology Hematology, P.A. | Carcinoma, Non-Small-Cell Lung, Gastroesophageal Junction Cancer, Advanced Non-Small Cell Lung Cancer | 6 |
| Adventist Healthcare White Oak Medical Center | Interstitial Lung Disease, Progressive Pulmonary Fibrosis, Acute Myocardial Infarction | 3 |
| Jadestone Clinical Research, LLC | Acute Myocardial Infarction (AMI), Cardiovascular Risk, Influenza | 3 |
| Maryland Oncology Hematology | Cancer, Chronic Lymphocytic Leukemia (CLL), Metastatic Prostate Cancer | 3 |
| Maryland Oncology Hematology - Silver Spring | Untreated, Unresectable, or Metastatic Colorectal Cancer, Chronic Lymphocytic Leukemia, Multiple Myeloma | 3 |
| Food and Drug Administration | Age-Related Macular Degeneration, Cone Dystrophy, Cone Rod Dystrophy | 2 |
| Jadestone Clinical Research | COVID-19 Infection, COVID-19 SARS-CoV-2 Infection | 2 |
| Javara | Focal Epilepsy | 2 |
| Maryland Oncology Hematology P A | Carcinoma, Non-Small-Cell Lung, Early Breast Cancer | 2 |
| TSC Alliance | Adult Caregivers of Individuals With TSC, Lymphangioleiomyomatosis, Tuberous Sclerosis | 2 |
| Holy Cross Hospital - Silver Spring | Breast Cancer, Folate Receptor-Alpha Positive, Recurrent Ovarian Cancer | 2 |
| Children's National Medical Center, Children's Research Institute | Caregiver Burden, Tracheostomy | 1 |
| Childrens National Hospital | Palliative Care Education | 1 |
| Direct Biologics Investigational Site | ARDS, Acute Respiratory Distress Syndrome | 1 |
| Food and Drug Administration (FDA) | Glaucoma | 1 |
| Invivyd Investigative Site | COVID-19 | 1 |
| Javara - Privia Medical Group - Silver Spring Lockwood | Asthma | 1 |
| Javara Inc./Privia Medical Group - Silver Spring, MD - Columbia Pike | Proteinuric Kidney Disease | 1 |
| Maryland Oncology Hematology P.A. | Breast Cancer | 1 |
| Maryland Oncology Hematology, PA | Breast Cancer | 1 |
| Massive Bio SYNERGY-AI site | BRCA Gene Rearrangement, Bladder Cancer, Breast Cancer | 1 |
| Medical Center Orthotics & Prosthetics | Lower Extremity, Pareses | 1 |
| Medical Center Orthotics and Prosthetics - Silver Spring | Upper Limb Amputation Above Elbow, Upper Limb Amputation Below Elbow | 1 |
| Privia Medical Group, LLC - Kelly's Collaborative Care - Javara - PPDS | Type II Diabetes Mellitus | 1 |
Active & Upcoming Studies in Silver Spring (2026)
Recruiting trials in Silver Spring grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (35 active studies)
- A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · Phase 2, Phase 3 · Pfizer
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
Vaccines (5 active studies)
- Study of VYD2311 for the Prevention of COVID-19 · Phase 3 · Invivyd, Inc.
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Neurology & pain (3 active studies)
- Long-term Safety and Tolerability of BHV-7000 · Phase 2 · Biohaven Therapeutics Ltd.
- A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy · Phase 2, Phase 3 · Biohaven Therapeutics Ltd.
Cardiovascular (3 active studies)
Eye & vision (3 active studies)
- Retinal Blood Flow and Autoregulation · Phase 4 · University of Maryland, Baltimore
- Adaptive Optics Imaging of Outer Retinal Diseases · Food and Drug Administration (FDA)
Diabetes & metabolic (1 active study)
- A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus · Phase 2 · Corxel Pharmaceuticals
Common conditions studied in Silver Spring
- Breast Cancer (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Endometrial Cancer (4 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Carcinoma, Non-Small-Cell Lung (3 active studies). Recruiting Carcinoma, Non-Small-Cell Lung studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Asthma (2 active studies). Asthma research tests biologic therapies targeting IL-4, IL-5, and TSLP pathways for moderate-to-severe and eosinophilic disease.
- Cancer (2 active studies). Recruiting Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Fallopian Tube Cancer (2 active studies). Recruiting Fallopian Tube Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Silver Spring
- AstraZeneca
- Pfizer
- AbbVie
- Merck Sharp & Dohme LLC
- Biohaven Therapeutics Ltd.
Local regulations and guidelines
Clinical trials in Maryland are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Maryland research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Silver Spring. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Silver Spring
Hipa.ai aggregates every recruiting study in Silver Spring from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Silver Spring?
There are approximately 70 recruiting clinical trials in Silver Spring, Maryland listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Silver Spring pay participants?
Most recruiting trials in Silver Spring compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Silver Spring?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Silver Spring?
The most common conditions under active study in Silver Spring include Breast Cancer (4), Endometrial Cancer (4), Carcinoma, Non-Small-Cell Lung (3), Asthma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Silver Spring?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Silver Spring on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Silver Spring?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Silver Spring?
Recruiting research sites in Silver Spring include Holy Cross Hospital, Maryland Oncology Hematology, P.A., Adventist Healthcare White Oak Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Silver Spring right now?
The largest active categories in Silver Spring are Cancer & tumors (35), Vaccines (5), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.